GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (STU:17Q1) » Definitions » Days Sales Outstanding

Pharmaron Beijing Co (STU:17Q1) Days Sales Outstanding : 60.86 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pharmaron Beijing Co Days Sales Outstanding?

Pharmaron Beijing Co's average Accounts Receivable for the three months ended in Dec. 2024 was €303 Mil. Pharmaron Beijing Co's Revenue for the three months ended in Dec. 2024 was €454 Mil. Hence, Pharmaron Beijing Co's Days Sales Outstanding for the three months ended in Dec. 2024 was 60.86.

The historical rank and industry rank for Pharmaron Beijing Co's Days Sales Outstanding or its related term are showing as below:

STU:17Q1' s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.3   Med: 69.76   Max: 74.22
Current: 66.53

During the past 11 years, Pharmaron Beijing Co's highest Days Sales Outstanding was 74.22. The lowest was 55.30. And the median was 69.76.

STU:17Q1's Days Sales Outstanding is ranked better than
55.16% of 852 companies
in the Biotechnology industry
Industry Median: 72.615 vs STU:17Q1: 66.53

Pharmaron Beijing Co's Days Sales Outstanding declined from Dec. 2023 (68.39) to Dec. 2024 (60.86).


Pharmaron Beijing Co Days Sales Outstanding Historical Data

The historical data trend for Pharmaron Beijing Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co Days Sales Outstanding Chart

Pharmaron Beijing Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.38 54.01 55.87 66.85 68.45

Pharmaron Beijing Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.39 74.15 66.27 63.38 60.86

Competitive Comparison of Pharmaron Beijing Co's Days Sales Outstanding

For the Biotechnology subindustry, Pharmaron Beijing Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaron Beijing Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaron Beijing Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Pharmaron Beijing Co's Days Sales Outstanding falls into.


;
;

Pharmaron Beijing Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Pharmaron Beijing Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

Days Sales Outstanding (A: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (287.938 + 315.989) / 2 ) / 1610.198*365
=301.9635 / 1610.198*365
=68.45

Pharmaron Beijing Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (289.185 + 315.989) / 2 ) / 453.647*365 / 4
=302.587 / 453.647*365 / 4
=60.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaron Beijing Co  (STU:17Q1) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Pharmaron Beijing Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaron Beijing Co Business Description

Traded in Other Exchanges
Address
No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, HKG
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.

Pharmaron Beijing Co Headlines

No Headlines